Justin Holko | VP, IR |
Leonard Schleifer | Co-Founder, President, CEO & Executive Director |
George Yancopoulos | Scientific Founder, President, Chief Scientific Officer & Director |
Marion McCourt | EVP, Commercial |
Robert Landry | EVP, Finance & CFO |
Geoffrey Porges | SVB Leerink |
Christopher Raymond | Piper Sandler & Co. |
Yaron Werber | Cowen and Company |
Joshua Schimmer | Evercore ISI |
Carter Gould | Barclays Bank |
Kennen MacKay | RBC Capital Markets |
Aaron Gal | Sanford C. Bernstein & Co. |
Robyn Karnauskas | Truist Securities |
Alethia Young | Cantor Fitzgerald & Co. |
Esther Rajavelu | UBS |
Yatin Suneja | Guggenheim Securities |
Good day, and thank you for standing by. Welcome to the Regeneron Pharmaceuticals Third Quarter Earnings Conference Call. [Operator Instructions]. I would now like to hand the conference over to your speaker today, Justin Holko, Vice President of Investor Relations. Please go ahead.